|
Volume 271, Number 48,
Issue of November 29, 1996
pp. 30426-30435
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Biogenetic Anatomy of Vitamin B6
A 13C NMR INVESTIGATION OF THE BIOSYNTHESIS OF
PYRIDOXOL IN ESCHERICHIA COLI*
(Received for publication, June 28, 1996, and in revised form, September 9, 1996)
Robert E.
Hill
,
Klaus
Himmeldirk
§,
Isaac A.
Kennedy
§,
Richard
M.
Pauloski
§,
Brian G.
Sayer
§,
Eckardt
Wolf
§ and
Ian D.
Spenser
§¶
From the Departments of § Chemistry and
Pathology, McMaster University, Hamilton,
Ontario L8S 4M1, Canada
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES
ABSTRACT
It is shown by incorporation experiments with
13C bond-labeled substrates, followed by analysis by means
of 13C NMR spectroscopy, that two compounds,
1-deoxy-D-xylulose (12) and
4-hydroxy-L-threonine (13), serve as precursors of
pyridoxol (vitamin B6) (1) in Escherichia coli.
Together, these two compounds account for the entire C8N
skeleton of the vitamin. 1-Deoxy-D-xylulose supplies the
intact C5 unit, C-2 ,2,3,4,4 of pyridoxol.
4-Hydroxy-L-threonine undergoes decarboxylation in
supplying the intact C3N unit, N-1,C-6,5,5 . Both
precursors are ultimately derived from glucose. The C5 unit of pyridoxol that is derived from 1-deoxy-D-xylulose
originates by union of a triose phosphate (yielding C-3,4,4 ) with
pyruvic acid (which decarboxylates to yield C-2 ,2).
D-Erythroate (11) enters the C3 unit, C-6,5,5 ,
and is therefore an intermediate on the route from glucose into
4-hydroxy-L-threonine.
INTRODUCTION
Our early work on the biosynthesis of vitamin B6 in
Escherichia coli mutants WG2 and WG3, based on studies
originally using substrates labeled with 14C and
3H (1, 2, 3, 4), and later substrates singly labeled with
13C (5), established the pattern of incorporation into the
skeleton of pyridoxol (1; see Structure 1)
of the carbon atoms of glycerol, glucose, and pyruvic acid. From these
results it was inferred that pyridoxol is constructed from three
glucose-derived triose phosphates, two of which enter intact, supplying
the C3 fragments, C-3,4,4 and C-6,5,5 of pyridoxol, with
the carbon atom holding the phosphate ester group yielding C-4 and
C-5 , while the third triose phosphate unit yields a C2
unit, by decarboxylation of pyruvate, whose CH3-CO moiety
then supplies the C2 unit, C-2 ,2, i.e. the
CH3 group and the adjacent ring carbon of pyridoxol.
Scheme 1.
The synthesis of potassium
[2,3-13C2]D-erythroate
( ) from [1,2-13C2]acetylene
( ).
[View Larger Version of this Image (21K GIF file)]
We now furnish definitive proof that these inferences were indeed
correct. This direct evidence comes from the results of incorporation
studies with substrates labeled with 13C at contiguous
sites, so called "bond-labeled" compounds, whose mode of
incorporation into pyridoxol was determined by 13C nuclear
magnetic resonance spectroscopy (13C NMR).
The power of this method lies in the circumstance that, when contiguous
carbon atoms within a compound are 100% enriched in 13C,
this fact is indicated by the presence, within the 13C NMR
spectrum of the compound, of 13C-13C coupling,
which is indicated by the appearance of peaks that are not present in
the spectrum of a natural abundance sample or of a singly
13C-enriched sample. These new peaks are detectable even if
the fully 13C enriched sample is a minor component of a
mixture that consists mainly of the unenriched compound.
The appearance of peaks due to 13C-13C
coupling, in the signals of the 13C NMR spectrum of a
biosynthetic product, as a result of incorporation of contiguously
100% 13C-13C-enriched (i.e.
bond-labeled) substrates, provides direct evidence for the transfer
from substrate into the biosynthetic product of an intact C-C unit. The
application of bond-labeled samples thus constitutes a powerful tool
for the demonstration of the transfer of intact multi-carbon fragments
in biosynthetic investigations; provided adequate incorporation can be
achieved in a tracer experiment with a 13C bond-labeled
substrate, these are the tracers of choice. Neither radioactive tracer
methods nor the use of substrates that are enriched with stable
isotopes at single sites can show incorporation of intact multi-carbon
units. Furthermore, 13C NMR does not only detect the site
of labeling, but at the same time confirms the identity of the labeled
sample and determines its degree of chemical purity. A precondition of
the application of NMR methods for the analysis of biosynthetic
incorporation patterns is the reliable assignment of each spectral
signal to the individual atom that gives rise to it.
Support for the inferences drawn from our tracer studies with
14C-labeled substrates, that the pyridoxine skeleton was
constructed from three glucose-derived subunits, came from an
experiment with [1,2,3,4,5,6-13C6]D-glucose
(referred to as Experiment 1 in Table I) (6, 7), which demonstrated
that, as predicted, only two carbon-carbon bonds, those between C-2 and
C-3 and between C-4 and C-5, are newly formed in the course of the
biosynthetic derivation of pyridoxol from glucose, and that glucose
does indeed supply three intact multicarbon units, as the building
blocks of the three fragments, C-2 ,2, C-3,4,4 , and C-6,5,5 , of
pyridoxol (Fig. 1, A).
Table I.
Experimental details
Each experiment (except Experiment 9) consisted of five 1-liter
incubations. Pyridoxol hydrochloride was isolated from the culture
fluid of each of the five incubations, after removal of the cells by
centrifugation and addition of unlabeled pyridoxol hydrochloride (2.5 mg) as carrier.
| Exp.
no. |
Substrates |
Weight |
13C NMR spectrum of isolated
pyridoxol HCl
|
|
|
|
mg/liter
(mmol)
|
| 1 |
[1,2,3,4,5,6-13C6]-D-Glucose |
200 (5.6) |
A
(Fig. 1; Refs. 6 and 7) |
|
D-Glucose |
800
|
| 2 |
[1,2-13C2]-D-Glucose |
300 (5.6) |
B
(Fig. 2) |
|
D-Glucose |
700 |
| 3 |
Sodium
[2,3-13C2]Pyruvate |
150 (1.3) |
C (Fig. 2)
|
|
D-Glucose |
1000 (5.6) |
| 4 |
Sodium
[2,3-13C2]Pyruvate |
200 (1.8) |
Not shown
|
|
D-Xylosea |
500 (3.3) |
(similar to
C)
|
| 5 |
[1,2,3,4,5,6-13C6]-D-Glucose |
200 (5.6) |
D
(Fig. 3) |
|
D-Glucose |
800
|
|
1-Deoxy-D-xylulose |
750 (5.6)
|
| 6 |
[2,3-13C2]-1-Deoxy-D-xylulose |
200 (1.5) |
F
(Fig. 4) |
|
D-Xylosea |
500 |
(3.3)
|
|
4-Hydroxy-L-threonineb |
100 (0.74)
|
|
L-Threoninec |
20 (0.17)
|
| 7 |
[1,2,3,4,5,6-13C6]-D-Glucose |
200 (5.6) |
E
(Fig. 3) |
|
D-Glucose |
800
|
|
4-Hydroxy-L-threonine |
750 (5.5)
|
|
L-Threoninec |
20 (0.17)
|
| 8 |
[2,3-13C2]-4-Hydroxy-L-threonine |
160 (1.2) |
G
(Fig. 5) |
|
D-Glucose |
500 (2.8)
|
|
L-Threoninec |
20 (0.17)
|
| 9d |
Potassium
[2,3-13C2]-D-erythroate |
200 (1.1) |
H
(Fig. 5)
|
|
D-Xylosea |
500 (3.3) |
|
a
In Experiments 4, 6, and 9, D-xylose in
place of D-glucose was used as the general carbon source in
order to avert the possibility that the presence of glucose might limit
the uptake and incorporation of the labeled carbohydrate substrates,
[2,3-13C2]-1-deoxy-D-xylulose (Experiment
6) and [2,3-13C2]-D-erythroate
(Experiment 9). Experiment 4 served as a test of D-xylose
as the general carbon source. This change in the general carbon source
was made after consideration of the results of the D-glucose displacement experiments, Experiments 5 and 7, and after failure to observe 13C incorporation in an early
experiment with
[2,3-13C2]-1-deoxy-D-xylulose. Whereas
unlabeled 4-hydroxy-L-threonine completely suppressed the
incorporation, into C-6,5,5 of pyridoxol, of 13C from
[1,2,3,4,5,6-13C6]-D-glucose (Experiment
7), unlabled 1-deoxy-D-xylulose only partially suppressed
the incorporation, into C-2 ,2,3,4,4 of pyridoxol, of 13C from
[1,2,3,4,5,6-13C6]-D-glucose (Experiment
5). Furthermore, in an experiment with [2,3-13C2]-1-deoxy-D-xylulose in which
D-glucose served as the general carbon source, no
13C enrichment was detectable in the pyridoxol that was
isolated. We reasoned that these results may have been the consequence
of an "inducer exclusion effect," a phenomenon that occurs in
bacterial systems, whereby certain carbohydrates (so-called
"PTS-carbohydrates"), e.g. glucose, inhibit the
transport and metabolism of other carbohydrates (so-called "class I
non-PTS carbohydrates") (PTS = phosphoenolpyruvate:carbohydrate phosphotransferase system) (16) of which 1-deoxy-D-xululose might be one. We surmised that in our short term (6 h) incubations, D-glucose might have inhibited the uptake of
1-deoxy-D-xululose, whereas entry of the amino acid,
4-hydroxy-L-threonine, had not been affected. If this
reasoning were correct, the problem might be overcome by using as the
general carbon source in this experiment a non-PTS-carbohydrate such as
D-xylose, in place of D-glucose, a
PTS-carbohydrate. Cultures of E. coli mutant WG2 were
established on the minimal medium, with D-xylose as the
general carbon source, and in a test experiment (Experiment 4) it was
found that under these conditions incorporation of label from sodium
[2,3-13C2]pyruvate matched the result obtained when
D-glucose served as the general carbon source (Experiment
3). Having thereby established that D-xylose could replace
D-glucose as the general carbon source without measurable
impairment of pyridoxine biosynthesis, we proceeded with Experiments 6 and 9 (Table I).
|
|
b
When this experiment (Experiment 6) was performed, it was
already known, from Experiments 7 and 8, that
4-hydroxy-L-threonine serves as a direct precursor of
pyridoxol. A sample of the amino acid was added since it was observed
that this stimulates pyridoxol biosynthesis.
|
|
c
4-Hydroxy-L-threonine shows antimetabolite
properties in E. coli, inhibiting the growth of E. coli B when cultured on a pyridoxine-supplemented growth medium.
Addition of L-threonine (20 mg/liter) permits the mutant to
grow in the presence of the amounts of
4-hydroxy-L-threonine that were added to the medium in
Experiments 6, 7, and 8 (100, 750, and 160 mg/liter, respectively).
|
|
d
Only three 1 liter cultures (rather than five) were employed
in this experiment.
|
|
Fig. 1.
13C NMR spectrum of
pyridoxol hydrochloride, biosynthetically derived in E. coli B mutant WG2 from
[1,2,3,4,5,6-13C6]glucose (6, 7).
[View Larger Version of this Image (18K GIF file)]
The results of the tracer studies with 13C bond-labeled
substrates that are here presented define more precisely the mode of incorporation of glucose carbon atoms into the glucose-derived subunits, C-2 ,2, C-3,4,4 and C-6,5,5 , of pyridoxol. They show, further, that an intact C2 unit, derived from C-3,2 of
pyruvic acid, serves as the precursor of the C2-unit,
C-2 ,2, and that the C5 chain, C-2 ,2,3,4,4 of pyridoxol,
originates by linear combination of the pyruvate-derived C2
unit and one of the glucose-derived C3 units. Furthermore,
the results establish the identities of the two multicarbon precursors
whose union accounts for the formation of the complete skeleton of
pyridoxine. It is shown that 1-deoxy-D-xylulose (12) supplies the intact C5 chain,
C-2 ,2,3,4,4 , while the C3N unit, N-1,C-6,5,5 , is derived
intact from 4-hydroxy-L-threonine (13), which is
thereby proven to be an intermediate of the biosynthetic route.
D-Erythroate (11) is shown to serve as an
intermediate between glucose and 4-hydroxy-L-threonine. Preliminary reports of part of this work have appeared elsewhere (8, 9, 10).
EXPERIMENTAL PROCEDURES
Organism
The organism used in these investigations was E. coli
B strain WG2. This is a pyridoxine auxotroph
(pdxH ) that lacks pyridoxol-phosphate oxidase
(EC 1.1.1.65 or EC 1.4.3.65).
Media
Nutrient Medium
This was a nutrient broth medium (Oxoid
Ltd., London, United Kingdom) prepared according to the supplier's
instructions.
Minimal Salts Medium
The minimal salts medium contained the
following salts: 7 g/liter KH2PO4, 3 g/liter
K2HPO4, 1 g/liter
(NH4)2SO4, 0.1 g/liter MgSO4, and 0.01 g/liter CaCl2.
D-Glucose (Experiments 1-3, 5, 7, and 8) or
D-xylose (Experiments 4, 6, and 9) served as the general
carbon source. Pyridoxal hydrochloride was added to a concentration of
6 × 10 7 M when the minimal medium was
used to grow the pdxH mutant.
All media were prepared in distilled water and were sterilized by
autoclaving. The pyridoxal hydrochloride supplement solution was
sterilized by filtration.
Stock Cultures
Stock cultures of E. coli B WG2 were maintained on
monthly slants of the nutrient broth medium. After subculturing from
the previous month's stock, fresh slants were incubated 24 h at
37 °C and were then stored at 4 °C. Every time fresh stock slants
were prepared, slants of minimal salts medium, with and without
pyridoxal supplementation, were inoculated and incubated 24 h at
37 °C in order to monitor for the presence of wild-type
revertants.
Labeled Compounds
The following labeled compounds were acquired from a commercial
source (Cambridge Isotope Laboratories, Inc. (CIL)):
[1,2,3,4,5,6-13C6]D-glucose (98%
13C),
[1,2-13C2]D-glucose (99%
13C), and sodium
[2,3-13C2]pyruvate (99%
13C).
The following labeled compounds were prepared from commercial starting
materials by multi-step syntheses devised for the purpose. [2,3-13C2]4-Hydroxy-L-threonine
was synthesized (11) from [1,2-13C2]acetylene
(99% 13C) (CIL) in eight steps with an overall yield of
13%.
[2,3-13C2]1-Deoxy-D-xylulose was
synthesized (12) from ethyl
bromo[1,2-13C2]acetate (99% 13C)
(CIL) in 14 steps with an overall yield of 15%. Potassium
[2,3-13C2]D-erythroate
(11) was synthesized (Scheme 1) from
[1,2-13C2]acetylene (99% 13C)
(2) (CIL) in nine steps with an overall yield of 20%.
Scheme 1.
The synthesis of potassium
[2,3-13C2]D-erythroate
( ) from [1,2-13C2]acetylene
( ).
[View Larger Version of this Image (21K GIF file)]
Molecules that are fully enriched with 13C at contiguous
sites, particularly if such molecules have CS symmetry,
yield strongly coupled 13C NMR spectra. The enriched carbon
atoms and their neighbors form a "deceptively simple" ABX system
(13). The coupling constants were determined by simulating the spectra
using the XSIM computer program of Dr. Kirk Marat, Department of
Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Potassium
[2,3-13C2]D-erythroate
{Potassium
[2,3-13C2]-(2R,3R)-2,3,4-trihydroxybutanoate}
(11).
[2,3-13C2]1,4-Di(tert-butyldiphenylsilyloxy)-(Z)-but-2-ene
(5)
[2,3-13C2]-(Z)-But-2-ene-1,4-diol
(4) (1.05 g, 11.6 mmol) (prepared in two steps from
[1,2-13C2]acetylene (2) (CIL) via
[2,3-13C2]but-2-yne-1,4-diol (3);
Ref. 11) was dissolved in dry N,N-dimethylformamide (35 ml)
and imidazole (3.40 g, 50 mmol) was added.
tert-Butyldiphenylsilyl chloride (6.5 ml, 25 mmol) was added
dropwise by syringe, and the mixture was stirred 4 h at room
temperature. It was then poured into diethyl ether (150 ml) and
extracted first with water (150 ml), then with aqueous hydrochloric
acid (~5%, 2 × 50 ml), with saturated sodium bicarbonate solution (50 ml) and again with water (50 ml). The organic layer was
dried (MgSO4), the solvent evaporated, and the residue
chromatographed on silica gel (petroleum ether, followed by diethyl
ether/petroleum ether 1:5 v/v), to yield the product (5) as
a colorless oil (6.01 g, 91.6%).
1H NMR (200 MHz, CDCl3): 7.56-7.61 (m,
8H), 7.23-7.73 (m, 12H), 5.06-6.22 (dm,
1JC,H = 156 Hz, 2H), 4.07 (d,
3JH, H = 3.74 Hz, 4H), 0.97 (s,
18H).
13C NMR (75.5 MHz, CDCl3): 135.5, 133.6, 129.9 (enriched), 128.8, 127.6, 60.5 (X part of a deceptively simple
ABX system, 1JAB = 70 Hz,
1JAX = 45 Hz,
2JBX = 3 Hz), 26.8, 19.1.
IR1 (film): 1111 (vmax) cm 1.
ms (CI): m/z 584 (30%, m + NH4+), 311 (100%).
[2,3-13C2]1,4-Di-(O-tert-butyldiphenylsilyl)erythritol
{[2,3-13C2]meso-1,4-Di-(O-tert-butyldiphenylsilyloxy)butane-2,3-diol}
(6)
[2,3-13C2]1,4-Di(tert-butyldiphenylsilyloxy)-(Z)-but-2-ene
(5) (6.01 g, 10.6 mmol) was dissolved in
tert-butanol (21 ml). Tetrahydrofuran (8 ml), water (4 ml),
and N-methylmorpholine N-oxide (1.60 g, 13.7 mmol) were added, and the air above the mixture was displaced by
nitrogen. An aqueous solution of osmium tetroxide (4% w/v, 4 ml) was
added and the mixture stirred 4 h at room temperature, after which
time no starting material remained (TLC: Silica gel 60, ethyl
acetate/hexane 1:4). Sodium bisulfite (125 mg) in water (5 ml) was
added, followed by Florisil® (5.25 g) and the mixture was
stirred 10 min and was then filtered through silica gel and eluted with
ethyl acetate (250 ml). Solvent was evaporated and the residue
recrystallized from hexane (30 ml), yielding colorless crystals of the
product (6), m.p. 90 °C (3.48 g, 54.6%). The mother
liquor was concentrated and the residue chromatographed (Silica gel 60, diethyl ether/petroleum ether 1:7, v/v), yielding a further 1.11 g
(17.4%) of product, together with a mixed fraction from which an
additional 189 mg of 6 was obtained by crystallization.
Total yield was 4.78 g (75.0%).
1H NMR (300 MHz, CDCl3): 7.69-7.73 (m,
8H), 7.26-7.50 (m, 12H), 3.50-4.13 (dm,
1JC, H = 141 Hz, 2H), 3.92 (s, 4H),
2.75 (s (br.) 2H), 1.11 (s, 18H).
13C NMR (75.5 MHz, CDCl3): 135.5, 133.0, 129.8, 127.8, 71.9 (enriched), 65.1 (X part of a deceptively simple ABX
system, 1JAB = 43 Hz,
1JAX = 36 Hz,
2JBX = 6 Hz), 26.9, 19.2.
IR (KBr): 3511, 692 (vmax)
cm 1.
ms (CI): m/z 618 (15%, m + NH4+), 367 (100%), 131 (90%).
[2,3-13C2]1,4-Di-(O-tert-butyldiphenylsilyl)-2,3-O-isopropylideneerythritol
{[4,5-13C2]meso-4,5-Di-(O-tert-butyldiphenylsilyloxymethyl)-2,2-dimethyl-1,3-dioxolane}
(7)
Diol (6) (4.78 g, 7.95 mmol) was
dissolved in dry benzene (100 ml). 2,2-Dimethoxypropane (15 ml, 122 mmol) was added and the mixture heated to 80 °C. Pyridinium
p-toluenesulfonate (275 mg) was added and methanol removed
by azeotropic distillation (b.p. 54 °C), until the reaction was
complete (~1 h). Benzene (~75 ml) was distilled off, the mixture
cooled to room temperature, and diethyl ether added. The solution was
washed with water (2 × 50 ml), dried (MgSO4), and
concentrated in vacuo to yield the dioxolane (7)
(5.05 g, 100%).
1H NMR (200 MHz, CDCl3): 7.57-7.64 (m,
8H), 7.24-7.39 (m, 12H), 4.45-4.75 (m, 1H), 3.62-4.00 (m, 5H),
1.36 (s 3H), 1.32 (s, 3H), 0.96 (s, 18H).
13C NMR (75.5 MHz, CD2Cl2): 135.6, 135.5, 133.5, 133.4, 129.6, 127.7, 108.4, 77.4 (enriched), 63.2 (X part of a deceptively simple ABX system,
1JAB = 37 Hz,
1JAX = 40 Hz,
2JBX = 5 Hz), 27.8, 26.7, 25.3, 19.1.
IR (film): 1112 (vmax) cm 1.
ms (CI): m/z 658 (25%, m + NH4+), 565 (95%), 385 (100%).
[2,3-13C2]2,3-O-Isopropylideneerythritol
{[4,5-13C2]meso-4,5-Dihydroxymethyl-2,2-dimethyl-1,3-dioxolane}
(8)
Disilyl ether (7) (5.05 g, 7.95 mmol) was dissolved in tetrahydrofuran (40 ml). Water (0.5 ml, 28 mmol)
and a solution of tetra-n-butylammonium fluoride in
tetrahydrofuran (1 M, 24 ml) were added and the mixture
kept 90 min at room temperature. Florisil® (8.5 g) was
then added with stirring, which was continued for 10 min, and the
mixture was then filtered through a pad of silica gel and eluted with
ethyl acetate/methanol (1:1 v/v, 100 ml). The residue, obtained after
evaporation of the solvent, was chromatographed on silica gel (ethyl
acetate/hexane, 1:2 v/v, followed by ethyl acetate/methanol 1:1 v/v).
The oily product was further purified by vacuum distillation
(Kugelrohr, 1 mm Torr, 145 °C). Diol (8) was obtained as
an oil (1.20 g, 93%), which crystallized (m.p. 47 °C; literature
m.p. of the unenriched compound 38 °C (Ref. 14), 46-47 °C (Ref.
15)) after 2 weeks in the refrigerator.
1H NMR (200 MHz, CDCl3): 4.27 (dm,
1JC,H = 146 Hz, 2H), 3.77 (s
(br), 4H), 2.51 (s (br), 2H), 1.45 (s, 3H), 1.35 (s, 3H).
13C NMR (75.5 MHz, CDCl3): 108.4, 76.8 (enriched), 60.8 (X part of a deceptively simple ABX system,
1JAB = 38 Hz,
1JAX = 41 Hz,
2JBX = 4 Hz), 27.6, 25.1.
IR (KBr): 3300, 1041.2 (vmax)
cm 1.
ms (CI): m/z 165 (100%, m + 1+).
[2,3-13C2]1-O-Acetyl-2,3-O-isopropylidene-D-erythritol
{[4,5-13C2]-(4S,5R)-5-Acetoxymethyl-2,2-dimethyl-4-hydroxymethyl-1,3-dioxolane}
(9) (14)
Diol (8) (1.20 g, 7.3 mmol)
was dissolved in tert-butyl methyl ether (20 ml), vinyl
acetate (1 ml, 10.8 mmol) was added, followed by a sample of lipase
from Pseudomonas fluorescens (SAM 2, 80 mg, 3360 units), and
the mixture was stirred 4 d at 35 °C. The solid was then
filtered off and washed with tert-butyl methyl ether (80 ml). The filtrate was evaporated in vacuo and the residue chromatographed on silica gel (diethyl ether) to yield enantiomerically pure monoacetate (9) (1.11 g, 74%).
[ ]D25 = +17.9° (c = 1.00, CHCl3) (literature [ ]D of the
unenriched compound [ ]D20 = +16.6°
(c = 1, CHCl3) (14).)
1H NMR (200 MHz, CDCl3): 4.53-4.72 (m,
1H), 4.17-4.26 (m, 1H), 3.80-4.10 (m, 2H), 3.36 (s (br.) 2H), 2.49 (s
(br.), 1H), 2.01 (s, 3H), 1.41 (s, 3H), 1.30 (s, 3H).
13C NMR (50.3 MHz, CDCl3): 171.0, 108.9, 77.9 (enriched, dAB, 1JC,
C = 34 Hz), 74.5 (enriched, dAB,
1JC,C = 34 Hz), 63.3 (d,
1JC,C = 44 Hz), 61.2 (d,
1JC,C = 41 Hz), 27.5, 25.0, 20.7.
IR (film): 3468, 1742, 1044 (vmax)
cm 1.
ms (CI): m/z 224 (90%, m + NH4+), 207 (100% m + 1+).
[2,3-13C2]4-O-Acetyl-2,3-O-isopropylidene-D-erythroic
acid
{[4,5-13C2](4R,5R)-5-Acetoxymethyl-2,2-dimethyl-1,3-dioxolane-4-carboxylic
acid} (10)
Alcohol (9) (0.36 g, 1.7 mmol) was dissolved in acetonitrile (3.5 ml). Carbon tetrachloride (3.5 ml), water (5.5 ml), and sodium periodate (1.50 g, 70.2 mmol) were
added and air above the mixture was displaced by nitrogen. Ruthenium
trichloride trihydrate (50 mg, 0.2 mmol) was added and the mixture
stirred vigorously 3 h at room temperature. Brine (50 ml) and
methylene chloride (50 ml) were added, and the aqueous layer was
extracted with methylene chloride (4 × 50 ml). The combined
organic phase was dried (MgSO4) and the solvent removed
in vacuo. The residue was taken up in diethyl ether (5 ml)
and filtered through Celite®. Evaporation of the solvent
gave the product (10) as a colorless oil (364 mg, 94%).
[ ]D20 = +18.5° (c = 1.01, CHCl3).
1H NMR (200 MHz, CDCl3): 8.8-9.5 (s(br.),
1H), 4.97-5.12 (m, 1H), 4.08-4.51 (m, 3H), 2.08 (s, 3H), 1.61 (s,
3H), 1.42 (s, 3H).
13C NMR (50.3 MHz, CDCl3): 172.9, 170.4 (d,
1JC,C = 51 Hz), 111.5, 75.3 (enriched, dAB, 1JC,C = 33 Hz), 75.0 (enriched, dAB,
1JC,C = 33 Hz), 62.5 (d,
1JC,C = 42 Hz), 26.7, 25.0, 20.6.
IR (film): 3401 (vmax), 1771, 1729 cm 1.
ms (CI): m/z 238 (M + NH4+,
5%), 198 (100%).
Potassium
[2,3-13C2]D-erythroate
{Potassium
[2,3-13C2]-(2R,3R)-2,3,4-trihydroxybutanoate}
(11)
Acid (10) (222 mg, 1.0 mmol) was
dissolved in acetonitrile (7 ml). A 5:1 mixture of water and
concentrated hydrochloric acid (3 ml) was added, and the mixture was
stirred 3 h at room temperature. The solution was concentrated
in vacuo, the residue dissolved in methanol (2 ml), a
methanolic solution of potassium hydroxide (2.5 M, 1 ml)
was added, and the mixture stirred 90 min at room temperature. Addition
of diethyl ether (5 ml) induced the product to crystallize. The
crystalline product was filtered off, washed with diethyl ether (10 ml), and dried, yielding crude potassium erythroate (174 mg) as a
yellow powder.
The crude product (from several runs) (855 mg) was dissolved in water
(1.7 ml), methanol (5.1 ml) was added, and the mixture was stored
2 d in the refrigerator. Pure potassium erythroate (11)
(650 mg, 76%) was obtained as colorless leaflets. [ ]D20 = +11.0° (c = 1.12, H2O).
1H NMR (200 MHz, D2O): 4.14-4.43 (m, 1H),
3.24-3.62 (m, 3H).
13C NMR (50.3 MHz, D2O): 178.5 (X part of a
deceptively simple ABX system, AB = 28 Hz,
1JAB = 42 Hz,
1JAX = 70 Hz,
2JBX = 8 Hz), 74.0 (enriched,
dAB, 1JCC = 40 Hz), 73.1 (enriched, dAB, 1JCC = 40 Hz), 61.9 (X part of a deceptively simple ABX system ( AB = 13 Hz, 1JAB = 40 Hz, 1JAX = 45 Hz,
2JBX = 3 Hz).
IR (KBr): 3405, 3194, 1717, 1605 (vmax)
cm 1.
ms (ES): m/z 137 (100% m+).
Incubation in the Presence of Labeled Compounds
Each tracer experiment was started by subculturing from the
current month's nutrient broth stock slant onto a
pyridoxal-supplemented minimal medium slant, which had been prepared
with either 0.5% w/v D-glucose (Experiments 1-3, 5, 7, and 8) or 0.5% w/v D-xylose (Experiments 4, 6, and 9) as
the carbon source. The slant was incubated 24 h at 37 °C. Cells
from this slant were then used to inoculate 2 × 500-ml samples of
the same medium, one of which was supplemented with pyridoxal
hydrochloride, the other without pyridoxal supplementation. These
cultures were incubated on a rotary shaker (New Brunswick Scientific)
at 37 °C, until an optical density measurement at 600 nm indicated
that growth in the supplemented culture was well into the exponential
phase (approximately 12 h). Any growth in the unsupplemented
culture served to indicate the presence of wild-type revertants or
possible contaminants. If this were observed, the experiment could have
been aborted at this stage without any wastage of labeled substrate.
Fortunately, in our hands the pdxH mutation in
strain WG2 is very stable, and so far such an occasion has not arisen.
Nevertheless, the control unsupplemented culture was included in every
experiment as a precautionary measure.
The cells from the pyridoxal-supplemented culture were harvested by
centrifugation (10 min at 7000 rpm) and washed with sterile 0.9%
saline (3 × 100 ml). The washed cells were divided into two equal
portions, each one of which was resuspended in minimal salts medium
(500 ml) without pyridoxal but containing the appropriate carbon
source, the labeled substrate and other addends. These cultures were
incubated 6 h on the rotary shaker (400 rpm, 37 °C). In order
to obtain sufficient material for NMR investigation, each incubation
was repeated five times, except in Experiment 9, when labeled substrate
for only three repeat incubations was available. Details of the
components used in each of the experiments are presented in Table
I.
Isolation of Pyridoxol from the Culture Medium
Work-up of Bacterial Cultures
The contents of each 500-ml
culture flask from each of the two 500-ml incubation experiments with
13C-labeled substrate were centrifuged 10 min at 7000 rpm,
and the supernatant solutions decanted and combined. The solution was concentrated to 200 ml in vacuo on a rotary evaporator. The
concentrated solution was treated with acid to hydrolyze phosphate
esters; sulfuric acid (1 M, ~80 ml) was added until the
final pH of the solution was 1.5, and the mixture was autoclaved
(121 °C, 3 h). The solution was then evaporated to dryness
in vacuo on a rotary evaporator. The residue was dissolved
in potassium acetate/acetic acid buffer (0.2 M, pH 4.5, 200 ml) and the solution was filtered through a fine sintered glass filter.
Pyridoxol hydrochloride (2.5 mg) was added to the filtrate as a
carrier. This solution was then subjected to ion exchange
chromatography, as follows.
Chromatography
A cation exchange column was prepared as
follows. Dowex 50-X8 (200-400 mesh) was washed, in succession, with
water, hydrochloric acid (3 M), water, potassium hydroxide
solution (6 M), and water, until free of fine particles.
This material was loaded into a column (15 × 1.5 cm), which was
then washed with potassium hydroxide (6 M), followed by
water, until the pH of the eluate was approximately pH 9.
The solution containing the concentrate of the incubation (pH 4.5, 200 ml, see above) was applied to this column. Elution of the column was
carried out by stepwise increase in pH, with the following buffer
sequence: potassium acetate (0.2 M)/acetic acid (0.2 M), pH 5.0, 100 ml; potassium acetate (0.2 M)/acetic acid (0.2 M), pH 5.5, 100 ml;
potassium acetate (0.2 M)/acetic acid (0.2 M),
pH 6.0, 50 ml; boric acid (0.2 M)/ potassium chloride (0.2 M)/acetic acid (0.2 M), 200 ml, adjusted to pH
6.6 by addition of sodium hydroxide (0.2 M). Fractions (10 ml) were collected and assayed by UV spectroscopy in order to determine
the position of pyridoxol in the elution sequence. Pyridoxol was eluted
in the first six 10-ml fractions following the addition of the final buffer (pH 6.6).
A second Dowex 50-X8 (200-400-mesh) column (6 × 1 cm) was
prepared and washed with hydrochloric acid (0.1 M) until
the eluate was acidic. The pyridoxol fractions from the first column
were pooled, evaporated under reduced pressure, and redissolved in hydrochloric acid (0.1 M, 50 ml). The solution was then
applied to the second column, which was eluted with distilled water
until the eluate was neutral, and then with dilute ammonia (3%).
Up to this stage, each 1-liter incubation from each of the experiments
was worked up separately. Now, the ammoniacal eluates (10 ml) from the
repeat incubations (3 × 1 liter in Experiment 9, 5 × 1 liter in all other experiments) were pooled. The pooled solution was
evaporated under reduced pressure and the solid residue dissolved in a
small volume of anhydrous methanol (2 ml). This solution was applied to
a preparative plate for thin layer chromatography (thickness 2 mm,
Silica Gel G according to Stahl). Development was for 15 cm in the
solvent system tert-butyl alcohol/methylethylketone/ammonia (0.880)/water (4:3:2:1). The plate was dried, and the pyridoxol band
was identified by its characteristic blue fluorescence under UV light
(254 nm). The band was removed from the plate, and the pyridoxol
extracted from the silica gel by stirring overnight at 40 °C in
anhydrous methanol (40 ml). The resultant slurry was filtered through a
fine sintered glass filter. The filtrate was reduced to small volume
(1-2 ml), and three drops of hydrochloric acid (0.1 M)
were added. On addition of anhydrous ether, pyridoxol hydrochloride
crystallized.
Final purification was effected by sublimation at 125-130 °C and
2 × 10 3 mm. In most instances the yield of sublimed
pyridoxol hydrochloride, m.p. 205-206 °C (with decomposition)
(literature m.p. of the unenriched compound 204-205 °C (with
decomposition ) (17); 206-208 °C (18)), was 8-9 mg, that is
~75-80% of the total weight of unenriched carrier that had been
added. The sublimed product was dissolved in D2O and the
solution used for 13C NMR studies.
A summary of the 13C NMR parameters of pyridoxol
hydrochloride is presented in Table II.
RESULTS AND DISCUSSION
The 13C NMR spectrum (Fig. 1,
A) of the sample of pyridoxol hydrochloride isolated from a
culture of E. coli B mutant WG2 after incubation with
[1,2,3,4,5,6-13C6]D-glucose (6,
7) shows that the three fragments C-2 ,2, C-3,4,4 and C-6,5,5 are
derived from glucose as intact multi-carbon units (Scheme
2, A). However, the spectrum does not provide
information concerning the identity of the fragments of glucose from
which these units are derived.
Scheme 2.
The labeling pattern of pyridoxol, derived
from [1,2,3,4,5,6-13C6]glucose, and from
[1,2,3,4,5,6-13C6]glucose in the presence of
1-deoxy-D-xylulose ( ) or of
4-hydroxy-L-threonine ( ).
[View Larger Version of this Image (17K GIF file)]
The answer to this question can now be conclusively deduced from three
sets of labeling data. First, the 13C NMR spectrum (Fig.
2, B)2 of the
sample of pyridoxol from
D-[1,2-13C2]glucose (Experiment
2) shows that each of the signals due to the carbon atoms of the three
carbon pairs C-2 ,2 ( 16.5, 144.7, 1J2 ,2 = 46.4 Hz), C-4 ,4 ( 59.0, 142.5, 1J4 ,4 = 45.1 Hz), and C-5 ,5
( 60.1, 138.8, 1J5 ,5 = 48.0 Hz)
appears as a "triplet," composed of a central natural abundance
signal, originating from the carrier material that had been added to
facilitate isolation, straddled by a doublet, due to
13C-13C enrichment at contiguous carbon atoms.
No satellites appear at the signals due to C-3 ( 154.7) or C-6 ( 131.8). Thus, the spectrum shows that the labeled C2 unit
of the precursor had entered the three C2 units C-2 ,2,
C-4 ,4, and C-5 ,5 of pyridoxol intact. Second, it had been found
earlier (3) that label from [1-14C]D-glucose
(or from [6-14C]D-glucose) entered the three
carbon atoms, C-2 , C-4 , and C-5 of pyridoxol, and only these three
carbon atoms. This defines the orientation of entry into pyridoxol of
the intact multicarbon units of glucose. The glucose carbon atoms
yielding the three intact fragments derived from
[1,2,3,4,5,6-13C6]D-glucose enter
as follows: C-1,2 (or C-6,5)3 of glucose
yield carbon atoms C-2 and C-2, respectively, of the C2
unit C-2 ,2 of pyridoxol; and carbon atoms C-1,2,3 (or C-6,5,4)3 of glucose enter C-4 and C-5 , C-4 and C-5, and
C-3 and C-6, respectively, of the two C3 units C-4 ,4,3 and
C-5 ,5,6 of pyridoxol. The early inference that the two C3
units C-4 ,4,3 and C-5 ,5,6 of pyridoxol were derivable intact from
C-1,2,3 (or C-6,5,4)3 of D-glucose, with C-1
(or C-6)3 of the sugar giving rise to C-2 , C-4 , and C-5 ,
is thus confirmed, lending strong support to the early conclusion that
the two C3 units C-4 ,4,3 and C-5 ,5,6 of pyridoxol are
derivable intact from triose
phosphates.4
Fig. 2.
See Footnote 2. B, Experiment 2, [1,2-13C2]D-glucose.
C, Experiment 3, sodium
[2,3-13C2]pyruvate.
[View Larger Version of this Image (16K GIF file)]
Third, it is now confirmed (Fig. 2, C) by the experiments
with sodium [2,3-13C2]pyruvate (Experiments 3 and 4) that the C2 unit, C-2 ,2, of pyridoxol, inferred (3)
to be derived intact from the CH3-CO- fragment of pyruvic
acid, is indeed so derived. Satellites appear only at the signals due
to C-2 and C-2 ( 16.5, 144.7, 1J2 ,2 = 46.4 Hz).
The stage is thus set for an investigation of the identity of compounds
that might serve as more advanced precursors of the B6
skeleton. Since only two new C-C bonds, C-2,3 and C-4,5, are generated
in the course of pyridoxol biosynthesis from D-glucose (Scheme 2, A) and since it may reasonably be assumed that
these two bonds are not generated simultaneously, only two sets of
advanced precursors need to be considered.
One alternative set of advanced precursors consists of a C5
compound and a C3N unit. The C5 compound would
be generated by closure of the bond destined to become the C-2,3 bond
of pyridoxol, as the precursor of the C5 unit,
C-2 -2-3-4-4 of pyridoxol, originating by union of the
CH3-CO fragment of pyruvic acid (C-2 -2) with a triose
phosphate (C-3-4-4 ). The remaining portion of the pyridoxol skeleton
would then require a C3 precursor of the fragment
C-6-5-5 , or possibly a C3N precursor of the fragment
N-1-C-6-5-5 .
The other alternative assumes closure of the bond destined to become
the C-4,5 bond of pyridoxol. The advanced precursors would then be a
branched chain C6 compound, serving as the source of the
C6 unit, C-3-4(-4 )-5(-5 )-6, while the remaining portion of the pyridoxol skeleton, C-2 ,2,N-1, would require a C2N
unit derived from the CH3-CO fragment of pyruvic acid,
together with a nitrogen source.
In the first instance we decided to focus on the former of the two
alternatives, a possible origin of the pyridoxol skeleton by union of a
C5 plus C3N unit. This turned out to be the
right decision. This alternative demands that the C5 unit
must be derived from the CH3-CO fragment of pyruvate plus a
triose phosphate. The reaction of a triose phosphate,
D-glyceraldehyde 3-phosphate (or of
D-glyceraldehyde itself), with pyruvic acid, catalyzed by
pyruvate dehydrogenase (EC 1.2.4.1), occurs in many micro-organisms, including E. coli (21, 22). The reaction is accompanied by loss of the pyruvic acid carboxyl group, to yield a C5
compound, 1-deoxy-D-xylulose 5-phosphate (or
1-deoxy-D-xylulose (12, Scheme 2),
respectively).
Preliminary evidence that 1-deoxy-D-xylulose serves as a
precursor, supplying the C5 chain, C-2 ,2,3,4,4 came from
an experiment with
[1,1,1-(RS)-5-2H4]1-deoxy-D-xylulose.
Deuterium from this substrate entered pyridoxol in the predicted manner
(23). It remained to generate conclusive evidence that
1-deoxy-D-xylulose is indeed an intermediate on the route
from glucose into pyridoxol and that it is incorporated intact. To
prove intermediacy, it had to be demonstrated that the presence of
excess 1-deoxy-D-xylulose in the system spared the
incorporation of glucose carbon into the C5 unit
C-2 ,2,3,4,4 of pyridoxol. To prove intact incorporation, it had to be
demonstrated that the bond, generated in the formation of the compound,
i.e. the bond destined to become C-2,3 of pyridoxol, remains
intact in the course of entry of 1-deoxy-D-xylulose into
pyridoxol.
Evidence that each of the two conditions is fulfilled is provided by
Experiments 5 and 6, respectively. The 13C NMR spectrum
(Fig. 3, D) of the sample of pyridoxol
(Scheme 2, D), isolated after administration of
[1,2,3,4,5,6-13C6]D-glucose in
the presence of excess 1-deoxy-D-xylulose (12, Scheme 2), shows that the signals due to 13C enrichment at
C-2 ( 16.5), C-2 ( 144.7), C-3 ( 154.7), C-4 ( 142.5) and
C-4 ( 59.0) are less intense than the corresponding signals in the
spectrum of pyridoxol derived from
[1,2,3,4,5,6-13C6]D-glucose alone
(Fig. 1, A), whereas the signals due to C-6 ( 131.8), C-5
( 138.8), and C-5 ( 60.1) remained unchanged (8). The extent of
decrease in the incorporation of 13C into the carbon atoms
C-2, C-2 , C-3, C-4, and C-4 , relative to that into carbon atoms C-6,
C-5, and C-5 , is illustrated in the expanded spectrum (Fig. 3,
D ), which shows that the satellites at the signal due to
C-4 ( 59.0) are approximately 2.5 × less intense than those
at the signal due to C-5 ( 60.1). Thus, the presence of excess
1-deoxy-D-xylulose had reduced the level of incorporation
of glucose-derived 13C into the C5 unit,
C-2 ,2,3,4,4 of pyridoxol. It follows that 1-deoxy-D-xylulose lies on the route from glucose into
pyridoxol. The 13C NMR spectrum (Fig. 4,
F) of the sample of pyridoxol, isolated after administration
of [2,3-13C2]1-deoxy-D-xylulose
(12) (Experiment 6) shows satellites at the signals due to C-2 and C-3
( 144.7, 154.7, 1J2,3 = 73.0 Hz)
and nowhere else, proving incorporation of the substrate without
cleavage of its C-2,3 bond (10).
Fig. 3.
See Footnote 2. D, Experiment 5, [1,2,3,4,5,6-13C6]D-glucose in
the presence of 1-deoxy-D-xylulose. E,
Experiment 7, [1,2,3,4,5,6-13C6]D-glucose in
the presence of 4-hydroxy-L-threonine. D and E , expanded 55-65 spectral region.
[View Larger Version of this Image (19K GIF file)]
Fig. 4.
See Footnote 2. F, Experiment 6, [2,3-13C2]1-deoxy-D-xylulose.
F , expanded 140-160 spectral region.
[View Larger Version of this Image (13K GIF file)]
The evidence is thus complete that the intact C5 chain of
1-deoxy-D-xylulose serves as source of the C5
unit C-2 ,2,3,4,4 of pyridoxol. It remains for the future to determine
whether it is the free deoxypentulose or its 5-phosphate ester that
serves as the actual precursor.5
We now turn our attention to the identity of the C3N
precursor of N-1,C-6,5,5 of pyridoxol.
Since the C3 unit C-6,5,5 is generated from C-3,2,1 (or
from C-4,5,6) of glucose, we postulated (2) in our original working hypothesis that a triose phosphate is implicated in the derivation of
this unit. Difficulties arose with this notion when it was discovered
that the C2 unit, C-5 ,5, was derivable from glycolaldehyde (25, 26) and that the CN unit, C-6,N-1, originated intact from the
fragment -CH2-NH2 of glycine (27). On the basis
of these results, we inferred (20) that the C3N fragment,
N-1,C-6,5,5 , of pyridoxol might be derived from
4-hydroxy-L-threonine, which in turn might be formed by an
aldolase type condensation of glycolaldehyde plus glycine, in the
manner of the formation of L-serine from a formaldehyde
equivalent plus glycine, catalyzed by serine hydroxymethylase (EC
2.1.2.1). In an attempt to achieve a reconciliation of the incorporation results with glucose on the one hand and with
glycolaldehyde and glycine on the other, we postulated (20)
intermediacy of 1-aminopropane-2,3-diol, which might arise either from
4-hydroxy-L-threonine by decarboxylation, or from
D-glyceraldehyde by transamination. An attempt to support
this notion experimentally failed. Label from a 2H-labeled
sample of 1-aminopropane-2,3-diol was not incorporated into pyridoxol
(28).
A solution to the problem was conceived by Lam and Winkler (29), who
suggested, on the basis of genetic studies, that the glucose-derived
C3 unit, C-6,5,5 , of pyridoxol was generated not by way of
a glycolytic triose phosphate intermediate, but via intermediates
originating from the pentose phosphate pathway. The major impetus for
this idea was the parallelism, genetic, enzymic and structural, between
the conversion of D-glyceraldehyde 3-phosphate to
L-serine (via D-glyceric acid 3-phosphate,
3-hydroxypyruvic acid 3-phosphate, and 3-phosphoserine) and the
conversion, in the homologous series, of D-erythrose
4-phosphate into 4-hydroxy-L-threonine (via erythroic acid
4-phosphate, 3,4-dihydroxy-2-oxobutanoic acid 4-phosphate, and
4-hydroxy-L-threonine 4-phosphate). This new hypothesis is
consistent with the results of the tracer experiments with
14C-labeled substrates on which the earlier hypothesis had
been based (30). The glycolaldehyde/glycine route to
4-hydroxy-L-threonine was regarded as an alternative minor
pathway.
We now provide the first direct experimental evidence in support of the
ideas of Lam and Winkler.
To prove that 4-hydroxy-L-threonine (13, Scheme
2) lies on the route from glucose into pyridoxol, it had to be
demonstrated that its presence in the system in excess spared the
incorporation of glucose carbon into the C3 unit C-6,5,5
of pyridoxol. To prove intact incorporation of
4-hydroxy-L-threonine, it had to be demonstrated that the
bond, generated in the formation of the compound from glycolaldehyde
and glycine, i.e. the bond destined to become C-5,6 of
pyridoxol, remains intact in the course of entry of
4-hydroxy-L-threonine into pyridoxol. Finally, to
substantiate the proposal of Lam and Winkler, that the compound
originated from glucose via the pentose phosphate route, direct
evidence of the intermediacy of a compound related to the proposed
route was required.
Evidence that each of these three conditions is fulfilled is provided
by Experiments 7, 8, and 9, respectively. The 13C NMR
spectrum (E, Fig. 3) of the sample of pyridoxol, isolated
after administration of
[1,2,3,4,5,6-13C6]D-glucose in
the presence of excess 4-hydroxy-L-threonine (Experiment 7)
shows that the signals due to C-6, ( 131.8), C-5 ( 138.8), and
C-5 ( 60.1) appear as singlets, whereas those due to the other five
carbon atom all maintain their multiplicity (8). The presence of excess
4-hydroxy-L-threonine had completely suppressed incorporation of glucose-derived 13C into the
C3 unit, C-6,5,5 of pyridoxol, while incorporation of
glucose-derived 13C into the rest of the molecule was
unaffected (Scheme 2, E; Fig. 3). Thus,
4-hydroxy-L-threonine lies on the route from glucose into
pyridoxol. The 13C NMR spectrum (Fig. 5,
G) of the sample of pyridoxol, isolated after administration
of
[2,3-13C2]4-hydroxy-L-threonine
(11) (Experiment 8) shows satellites at the signals due to C-5 and C-6
( 138.8, 131.8, 1J5,6 = 64.9 Hz),
and nowhere else, proving incorporation of the substrate without
cleavage of the C-2,3 bond (9).
Fig. 5.
See Footnote 2. G, Experiment 8, [2,3-13C2]4-hydroxy-L-threonine.
H, Experiment 9, potassium
[2,3-13C2]D-erythroate.
G and H , expanded 130-140 spectral
region.
[View Larger Version of this Image (23K GIF file)]
Finally, the 13C NMR spectrum (Fig. 5, H) of the
sample of pyridoxol, isolated from an experiment with
[2,3-13C2]D-erythroic acid
(Experiment 9), showed that bond-label had been transferred from the
substrate into C-6,5 of pyridoxol. This result represents the first
direct evidence in support of the proposal of Lam and Winkler (29).
Satellites, which are clearly visible in the expanded spectrum (Fig. 5,
H ), appear at the signals due to C-5 and C-6 ( 138.8, 131.8, 1J5,6 = 64.9 Hz).
The evidence is thus complete that the C3N unit that serves
as the source of N-1,C-6,5,5 of pyridoxol is derived from
4-hydroxy-L-threonine, and that the latter is derived from
glucose via erythroic acid. Recent results indicate that the first
vitamin B6 compound to be formed in E. coli is
pyridoxol 5 -phosphate, rather than pyridoxol (31, 32). Even though the
nonphosphorylated compounds, 4-hydroxy-L-threonine and
D-erythroic acid, were incorporated intact into the
C3N unit, N-1,C-6,5,5 of pyridoxol, it would appear more
likely that 4-hydroxythreonine 4-phosphate (33) and erythroic acid
4-phosphate, rather than the non-phosphorylated compounds, serve as the
precursors. The presence in E. coli of a nonspecific kinase
would account for the utilization, in our experiments, of the
nonphosphorylated compounds.
The status of the alternative source of the C3N unit
N-1,C-6,5,5 of pyridoxol and, presumably, also of its precursor,
4-hydroxy-L-threonine, i.e. its derivation from
glycolaldehyde plus glycine, must now be evaluated.
Glycolaldehyde satisfies the nutritional requirement for pyridoxol in
the pdxB E. coli B mutant, WG3
(34). The evidence is unequivocal that glycolaldehyde is incorporated
into pyridoxal. In this mutant (25), as well as in the
pdxH mutant WG2 (26), label from specifically
14C-labeled glycolaldehyde enters C-5,5 . The aldehyde
carbon of glycolaldehyde supplies C-5 of pyridoxal and the carbinol
carbon supplies C-5 (25, 26). Furthermore, in mutant WG3, the N-C bond
of the NH2-CH2- group of glycine yields the
N-1,C-6 bond of pyridoxal (27). This incorporation pattern is entirely
consistent with the notion that 4-hydroxy-L-threonine, the
precursor of the C3N unit N-1,C-6,5,5 , is synthesized not
only from D-glucose via D-erythroic acid, but
also from glycine plus glycolaldehyde (20), by a reaction analogous to
that normally catalyzed by serine hydroxymethylase.
Whether or not this alternative derivation of
4-hydroxy-L-threonine is a normal, if minor, source of this
compound or whether it is induced only if glycolaldehyde is supplied to
the medium is a question that cannot be answered on the basis of
available knowledge. However, we incline to the view that, unless
further more direct evidence becomes available, the
glycolaldehyde/glycine route to 4-hydroxy-L-threonine and
thence into the C3N unit, N-1,C-6,5,5 , of pyridoxol should
be regarded as an artifact, which is observed only when glycolaldehyde
is supplied to the culture medium.
Only five pdx genes, pdxA, pdxB,
pdxH, pdxJ, and SerC (pdxF)
have been identified in E. coli. The protein product of
pdxH is pyridoxol 5 -oxidase (EC 1.1.3.13) (31, 32).
pdxB codes for the enzyme that oxidises
D-erythroic acid 4-phosphate to
2-oxo-D-erythroic acid 4-phosphate (EC 1.1.1.?) (35). The
latter compound, in turn, is transaminated to
4-hydroxy-L-threonine 4-phosphate by 3-phosphoserine
transaminase (EC 2.6.1.62), the product of SerC (pdxF) (29). The protein products of pdxA and
pdxJ are unknown. Since neither
pdxA nor pdxJ mutants
are supported by 4-hydroxy-L-threonine (28), it can be
deduced that pdxA and pdxJ are not implicated in
the production of this amino acid. Nor is it likely that these genes
are involved in the route to 1-deoxy-D-xylulose, since this
substrate is a precursor, in E. coli, not only of pyridoxine
but also of thiamin (10), and neither pdxA nor
pdxJ mutants require thiamin for growth on a
minimal medium. The remaining possibility is that the gene products of
pdxA and pdxJ play a role in the reaction
sequence that generates pyridoxol from the two intermediates,
4-hydroxy-L-threonine and 1-deoxy-D-xylulose. A
biochemically and chemically rational hypothesis for the union of these
two substrates to yield pyridoxol has been advanced (30). This
reaction sequence and the possible involvement of the gene products of
pdxA and pdxJ remain to be substantiated
experimentally.
FOOTNOTES
*
This work was supported by Grant GM 50778 from NIGMS,
National Institutes of Health (to I. D. S.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.: 905-525-9140 (ext. 23245); Fax: 905-522-2509; E-mail:
spenser{at}mcmail.cis.mcmaster.ca.
1
The abbreviations used are: IR, infrared
spectrum; ms, mass spectrum; m.p., melting point.
2
Figs. 2, 3, 4, 5, A-H: 125.776-MHz proton
decoupled 13C NMR spectra of pyridoxol hydrochloride (in
100 µl of D2O), isolated from E. coli B mutant
WG 2 after incubation with the 13C bond-labeled substrate
that is listed below each figure. The spectra were acquired on a Bruker
DRX 500 spectrometer, operating at 11.74 T, using a Bruker 2.5 mm
microprobe, with a 90° pulse width (8 µs), spectral width 28985.5 Hz, and a recycle time of 10.6 s. Digital resolution was 0.88 Hz
per data point.
3
Since the two C3 fragments of
glucose, C-1,2,3 and C-6,5,4, are interconvertible via triose-phosphate
isomerase (EC 5.3.1.1)-catalyzed equilibration of dihydroxyacetone
1-phosphate (from C-1,2,3 of glucose) and D-glyceraldehyde
3-phosphate (from C-4,5,6 of glucose), the experiment does not
distinguish between the ultimate derivation of these three
C2 units from C-1,2 or from C-6,5 of glucose.
4
It must be stated at this point that the
inferences that we drew (19, 20) concerning the identity of the triose
phosphate that entered each the two C3 units, on the basis
of the quantitative distribution within pyridoxol of radioactivity from
[1-14C]- and [6-14C]D-glucose
(4), were incorrect. This will be referred to later.
5
A suggestion (24), conceived to explain recent
microbiological observations, that under anaerobic conditions
1-deoxy-D-xylulose is replaced as the precursor of the
C5 unit by the corresponding aldehyde,
(2S,3R)-2,3-dihydroxy-4-oxopentanal, remains
entirely hypothetical.
Acknowledgment
We are greatly indebted to Dr. A. D. Bain,
Department of Chemistry, McMaster University, who generously provided
his expertise in the interpretation of the deceptively simple
spectra of the bond-labeled intermediates of the synthesis of
potassium
[2,3-13C2]D-erythroate.
REFERENCES
-
Hill, R. E., and Spenser, I. D.
(1970)
Science
169,
773-775
[Medline]
[Abstract/Free Full Text]
-
Hill, R. E., Gupta, R. N., Rowell, F. J., and Spenser, I. D.
(1971)
J. Am. Chem. Soc.
93,
518-520
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hill, R. E., Rowell, F. J, Gupta, R. N., and Spenser, I. D.
(1972)
J. Biol. Chem.
247,
1869-1882
[Medline]
[Abstract/Free Full Text]
-
Hill, R. E., and Spenser, I. D.
(1973)
Can. J. Biochem.
51,
1412-1416
[Medline]
; Correction (1974) Can. J. Biochem. 52, 271
[Medline]
[Order article via Infotrieve]
-
Hill, R. E., Miura, I., and Spenser, I. D.
(1977)
J. Am. Chem. Soc.
99,
4179-4181
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hill, R. E., Iwanow, A., Sayer, B. G., Wysocka, W., and Spenser, I. D.
(1987)
J. Biol. Chem.
262,
7463-7471
[Medline]
[Abstract/Free Full Text]
-
612614Hill, R. E., Sayer, B. G., and Spenser, I. D. (1986) J. Chem.
Soc. Chem. Commun. 612-614
-
Kennedy, I. A., Hill, R. E., Pauloski, R. M., Sayer, B. G., and Spenser, I. D.
(1995)
J. Am. Chem. Soc.
117,
1661-1662
[CrossRef]
-
13391340Wolf, E., Hill, R. E., Sayer, B. G., and Spenser, I. D. (1995) J. Chem. Soc. Chem. Commun. 1339-1340
-
11871188Himmeldirk, K., Kennedy, I. A., Hill, R. E., Sayer, B. G., and Spenser,
I. D. (1996) J. Chem. Soc. Chem. Commun. 1187-1188
-
Wolf, E., and Spenser, I. D.
(1995)
J. Org. Chem.
60,
6937-6940
[CrossRef]
-
Kennedy, I. A., Hemscheidt, T., Britten, J. F., and Spenser, I. D.
(1995)
Can. J. Chem.
73,
1329-1337
[CrossRef]
-
Bain, A. D., Wolf, E., Hughes, D. W., and Spenser, I. D.
(1996)
Croat. Chem. Acta
69,
681-688
-
Pottie, M., De Lathauwer, G., and Vandewalle, M.
(1994)
Bull. Soc. Chim. Belg.
103,
285-294
-
Komiotis, D., Pananookooln, S., Zaw, K., Dieter, J. P., LeBreton, G. C., and Venton, D. L.
(1995)
Eur. J. Med. Chem.
30,
321-326
[CrossRef]
-
Postma, P. W., Lengeler, J. W., and Jacobson, G. R.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed), 2nd Ed., Vol. 1, pp. 1149-1174, ASM Press, Washington, D.C.
-
25832591Baddiley, J., and Mathias, A. P. (1952) J. Chem. Soc.
2583-2591
-
Brooks, H. G., Jr., Laakso, J. W., and Metzler, D. E.
(1966)
J. Heterocyc. Chem.
3,
126-128
-
Vella, G. J., Hill, R. E., and Spenser, I. D.
(1981)
J. Biol. Chem.
256,
10469-10474
[Medline]
; Correction (1982) J. Biol. Chem. 257, 4008
[Free Full Text]
-
Hill, R. E., and Spenser, I. D.
(1986)
in
Pyridoxal Phosphate: Chemical, Biochemical and Medical Aspects (Dolphin, D., Poulson, R., and Avramovic, O., eds), pp. 417-476, John Wiley & Sons, Inc., New York
-
Yokota, A., and Sasajima, K.
(1984)
Agric. Biol. Chem.
48,
149-158
-
Yokota, A., and Sasajima, K.
(1986)
Agric. Biol. Chem.
50,
2517-2524
-
Hill, R. E., Sayer, B. G., and Spenser, I. D.
(1989)
J. Am. Chem. Soc.
111,
1916-1917
[CrossRef]
-
Man, T.-K., Zhao, G., and Winkler, M. E.
(1996)
J. Bacteriol.
178,
2445-2449
[Medline]
[Abstract/Free Full Text]
-
16221627Hill, R. E., Horsewood, P., Spenser, I. D., and Tani, Y (1975) J. Chem. Soc. Perkin Trans. I 1622-1627
-
Vella, G. J., Hill, R. E., Mootoo, B. S., and Spenser, I. D.
(1980)
J. Biol. Chem.
255,
3042-3048
[Medline]
[Abstract/Free Full Text]
-
Iwanow, A., Hill, R. E., Sayer, B. G., and Spenser, I. D.
(1984)
J. Am. Chem. Soc.
106,
1840-1841
[CrossRef]
-
Drewke, Ch., Notheis, C., Hansen, U., Leistner, E., Hemscheidt, T., Hill, R. E., and Spenser, I. D.
(1993)
FEBS Lett.
318,
125-128
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lam, H.-M., and Winkler, M. E.
(1990)
J. Bacteriol.
172,
6518-6528
[Medline]
[Abstract/Free Full Text]
-
Spenser, I. D., and Hill, R. E.
(1995)
Nat. Prod. Rep.
12,
555-565
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhao, G., and Winkler, M. E.
(1995)
J. Bacteriol.
177,
883-891
[Medline]
[Abstract/Free Full Text]
-
Notheis, C., Drewke, C., and Leistner, E.
(1995)
Biochim. Biophys. Acta
1247,
265-271
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhao, G., and Winkler, M. E.
(1996)
FEMS Microbiol. Lett.
135,
275-280
[Medline]
[Medline]
[Order article via Infotrieve]
-
Dempsey, W. B.
(1971)
J. Bacteriol.
108,
1001-1007
[Medline]
[Abstract/Free Full Text]
-
Zhao, G., Pease, A. J., Bharani, N., and Winkler, M. E.
(1995)
J. Bacteriol.
177,
2804-2812
[Medline]
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. P. Craig, S. Bekal, M. Hudson, L. Domier, T. Niblack, and K. N. Lambert
Analysis of a Horizontally Transferred Pathway Involved in Vitamin B6 Biosynthesis from the Soybean Cyst Nematode Heterodera glycines
Mol. Biol. Evol.,
October 1, 2008;
25(10):
2085 - 2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gonzalez, D. Danehower, and M. E. Daub
Vitamer Levels, Stress Response, Enzyme Activity, and Gene Regulation of Arabidopsis Lines Mutant in the Pyridoxine/Pyridoxamine 5'-Phosphate Oxidase (PDX3) and the Pyridoxal Kinase (SOS4) Genes Involved in the Vitamin B6 Salvage Pathway
Plant Physiology,
November 1, 2007;
145(3):
985 - 996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xiang, G. Usunow, G. Lange, M. Busch, and L. Tong
Crystal Structure of 1-Deoxy-D-xylulose 5-Phosphate Synthase, a Crucial Enzyme for Isoprenoids Biosynthesis
J. Biol. Chem.,
January 26, 2007;
282(4):
2676 - 2682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tazoe, K. Ichikawa, and T. Hoshino
Flavin Adenine Dinucleotide-Dependent 4-Phospho-D-Erythronate Dehydrogenase Is Responsible for the 4-Phosphohydroxy-L-Threonine Pathway in Vitamin B6 Biosynthesis in Sinorhizobium meliloti
J. Bacteriol.,
July 1, 2006;
188(13):
4635 - 4645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tambasco-Studart, O. Titiz, T. Raschle, G. Forster, N. Amrhein, and T. B. Fitzpatrick
Vitamin B6 biosynthesis in higher plants
PNAS,
September 20, 2005;
102(38):
13687 - 13692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Raschle, N. Amrhein, and T. B. Fitzpatrick
On the Two Components of Pyridoxal 5'-Phosphate Synthase from Bacillus subtilis
J. Biol. Chem.,
September 16, 2005;
280(37):
32291 - 32300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wrenger, M.-L. Eschbach, I. B. Muller, D. Warnecke, and R. D. Walter
Analysis of the Vitamin B6 Biosynthesis Pathway in the Human Malaria Parasite Plasmodium falciparum
J. Biol. Chem.,
February 18, 2005;
280(7):
5242 - 5248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Cassera, F. C. Gozzo, F. L. D'Alexandri, E. F. Merino, H. A. del Portillo, V. J. Peres, I. C. Almeida, M. N. Eberlin, G. Wunderlich, J. Wiesner, et al.
The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum
J. Biol. Chem.,
December 10, 2004;
279(50):
51749 - 51759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ehrenshaft and M. E. Daub
Isolation of PDX2, a Second Novel Gene in the Pyridoxine Biosynthesis Pathway of Eukaryotes, Archaebacteria, and a Subset of Eubacteria
J. Bacteriol.,
June 1, 2001;
183(11):
3383 - 3390.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Estévez, A. Cantero, C. Romero, H. Kawaide, L. F. Jiménez, T. Kuzuyama, H. Seto, Y. Kamiya, and P. León
Analysis of the Expression of CLA1, a Gene That Encodes the 1-Deoxyxylulose 5-Phosphate Synthase of the 2-C-Methyl-D-Erythritol-4-Phosphate Pathway in Arabidopsis
Plant Physiology,
September 1, 2000;
124(1):
95 - 104.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Tazoe, K. Ichikawa, and T. Hoshino
Biosynthesis of Vitamin B6 in Rhizobium
J. Biol. Chem.,
April 6, 2000;
275(15):
11300 - 11305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Osmani, G. S. May, and S. A. Osmani
The Extremely Conserved pyroA Gene of Aspergillus nidulans Is Required for Pyridoxine Synthesis and Is Required Indirectly for Resistance to Photosensitizers
J. Biol. Chem.,
August 13, 1999;
274(33):
23565 - 23569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, G. Zhao, T.-K. Man, and M. E. Winkler
Involvement of the gapA- and epd (gapB)-Encoded Dehydrogenases in Pyridoxal 5'-Phosphate Coenzyme Biosynthesis in Escherichia coli K-12
J. Bacteriol.,
August 15, 1998;
180(16):
4294 - 4299.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Yang, H.-C. T. Tsui, T.-K. Man, and M. E. Winkler
Identification and Function of the pdxY Gene, Which Encodes a Novel Pyridoxal Kinase Involved in the Salvage Pathway of Pyridoxal 5'-Phosphate Biosynthesis in Escherichia coli K-12
J. Bacteriol.,
April 1, 1998;
180(7):
1814 - 1821.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. M. Lois, N. Campos, S. R. Putra, K. Danielsen, M. Rohmer, and A. Boronat
Cloning and characterization of a gene from Escherichia coli encoding a transketolase-like enzyme that catalyzes the synthesis of D-1-deoxyxylulose 5-phosphate, a common precursor for isoprenoid, thiamin, and pyridoxol biosynthesis
PNAS,
March 3, 1998;
95(5):
2105 - 2110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Sprenger, U. Schorken, T. Wiegert, S. Grolle, A. A. de Graaf, S. V. Taylor, T. P. Begley, S. Bringer-Meyer, and H. Sahm
Identification of a thiamin-dependent synthase in Escherichia coli required for the formation of the 1-deoxy-D-xylulose 5-phosphate precursor to isoprenoids, thiamin, and pyridoxol
PNAS,
November 25, 1997;
94(24):
12857 - 12862.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|